* Researchers at the Danish Headache Center are testing semaglutide along with a very low calorie diet as a treatment for new ...

Liver cancer is still relatively rare in the United States, representing 2.1% of all new cancer diagnoses in 2025. The report ...

Diabetes drugs from Eli Lilly and Novo Nordisk, such as Mounjaro, Zepbound, Ozempic, and Wegovy, are expanding beyond ...

Drugs made to treat diabetes and weight loss could stop or even reverse a severe liver disease, according to a new study. The international study led by a Virginia Commonwealth University ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

New research published Tuesday concludes that the rising rate of extreme childhood obesity—well above the usual BMI ...

The Canadian researcher has just received the Frontiers of Knowledge Award for his work on anti-obesity drugs. However, he ...

The risks of the new weight-loss drugs can sound scary, and there’s lots of talk about side effects. What does evidence show?

The race for oral GLP-1 weight loss drugs is intense. Pfizer drops a candidate, Eli Lilly shows progress, and Novo Nordisk seeks FDA approval for oral Wegovy.